Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
News|Slideshows|August 20, 2019
Adult Pneumococcal Vaccine: Who Needs It? When and Why?
Author(s)Terry Brenneman, MD
The rules for pneumococcal vaccination can seem a little arbitrary. See what you know about the ACIP rationale behind these 5 recommendations for PCV13 and PPSV23.
Advertisement
The rules for pneumococcal vaccine administration are well known to all healthcare providers but some of those rules can seem a little arbitrary. The Advisory Committee on Immunization Practices (ACIP) does have rationale for all its guidelines. See if you are familiar with the rationale behind these 5 recommendations.
Advertisement
Related to this article
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
Advertisement
Advertisement
Trending on Patient Care Online
1
ACOG Issues Expanded Guideline on Managing Menopause-Related Vasomotor, Sleep, and Mood Symptoms
2
Mirikizumab Linked to Higher Rates of Corticosteroid-Free Composite Remission in UC and Crohn Disease
3
FDA Grants Breakthrough Device Designation to Natera's Multi-Cancer Early Detection Blood Test
4
Who Should Get a CGM? Expanding the Primary Care Candidate Pool
5